OnKure raises $150 million to advance cancer treatment programs Mar 27, 2026 08:02AM
OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies Mar 27, 2026 08:00AM